Skip to content

Effects of a Dietary Fiber on Fecal Microbiota and Metabolism

Effects of a Dietary Fiber on Human Gut Microbiota, Bioactive Metabolites and Blood Glucose Control

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01518088
Enrollment
20
Registered
2012-01-25
Start date
2012-02-29
Completion date
2013-12-31
Last updated
2016-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus of the Study is on Gut Health

Brief summary

The purpose of the study is to examine how a dietary fiber affects metabolism in healthy overweight and obese adults. The fiber will be added to foods that participants will consume for two, three-week periods. The fiber will be given in two doses -- 15 g per day during one period, and 30 g per day in the other. In another three-week period, they will consume the same foods, but with no fiber added. Major outcomes will include fermentability of the fiber, as assessed by measurement of breath hydrogen, as well as shifts in fecal bacteria. The caloric value of the fiber will be determined and metabolic measures related to blood glucose control and inflammation will also be taken.

Interventions

DIETARY_SUPPLEMENTDietary Fiber

Dietary fiber will be added to study foods

Sponsors

Ingredion Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index from 25 to 35 kg/m2. * Willing to consume study foods and comply with dietary exclusions and specimen collection

Exclusion criteria

* Pregnancy * Diabetes * Gastrointestinal disease * Regular use of pre- or probiotics * Recent use of antibiotics * High intake of dietary fiber

Design outcomes

Primary

MeasureTime frameDescription
Metabolizable energy7 days, 3 timesUrine and feces will be collected for 7 days at the end of each treatment period to allow for assessment of metabolizable energy
FermentabilityOne, eight-hr day, three timesBreath hydrogen will be measured hourly, over eight hours at the end of each treatment period

Secondary

MeasureTime frameDescription
Fecal microbiota2 days, three times, and 7 days, three timesFecal samples will be collected for 7 days at the end of each treatment period and for two days during washout periods
Blood glucoseFor eight hours, three timesAn indwelling catheter will be placed and blood samples will be drawn over the course of an eight-hour period, at the end of each treatment period

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026